Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kyle Hadden

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|July 1, 2016
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer ChemotherapeuticsDmitry M Korzhnev, M Kyle Hadden
European Journal of Medicinal Chemistry|May 28, 2024
Small molecules that regulate the N<sup>6</sup>-methyladenosine RNA modification as potential anti-cancer agentsNoah J Harrahill, M Kyle Hadden
Bioorganic Chemistry|July 24, 2025
Structure and function of reader proteins that recognize methylated RNA residuesRuth M Ogboye, M Kyle Hadden
Expert Opinion on Drug Discovery|October 2, 2020
Targeting the GLI family of transcription factors for the development of anti-cancer drugsChristopher O Dusek, M Kyle Hadden
The Journal of Organic Chemistry|June 5, 2009
Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycinM Kyle Hadden, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitorsUpasana Banerjee, Manuka Ghosh, M Kyle Hadden
Bioorganic & Medicinal Chemistry Letters|July 28, 2007
Cytotoxic small molecule dimers and their inhibitory activity against human breast cancer cellsM Kyle Hadden, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|November 26, 2019
Inhibition of hedgehog signaling by stereochemically defined des-triazole itraconazole analoguesJiachen Wen, Kelly A Teske, M Kyle Hadden
Bioorganic & Medicinal Chemistry Letters|August 27, 2013
Analogues of the Inhoffen-Lythgoe diol with anti-proliferative activityAlbert M DeBerardinis, Steven Lemieux, M Kyle Hadden
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-activity relationships for side chain oxysterol agonists of the hedgehog signaling pathwayAudrey Corman, Albert M DeBerardinis, M Kyle Hadden
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|July 1, 2016
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer ChemotherapeuticsDmitry M Korzhnev, M Kyle Hadden
European Journal of Medicinal Chemistry|May 28, 2024
Small molecules that regulate the N<sup>6</sup>-methyladenosine RNA modification as potential anti-cancer agentsNoah J Harrahill, M Kyle Hadden
Bioorganic Chemistry|July 24, 2025
Structure and function of reader proteins that recognize methylated RNA residuesRuth M Ogboye, M Kyle Hadden
Expert Opinion on Drug Discovery|October 2, 2020
Targeting the GLI family of transcription factors for the development of anti-cancer drugsChristopher O Dusek, M Kyle Hadden
The Journal of Organic Chemistry|June 5, 2009
Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycinM Kyle Hadden, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitorsUpasana Banerjee, Manuka Ghosh, M Kyle Hadden
Bioorganic & Medicinal Chemistry Letters|July 28, 2007
Cytotoxic small molecule dimers and their inhibitory activity against human breast cancer cellsM Kyle Hadden, Brian S J Blagg
Bioorganic & Medicinal Chemistry Letters|November 26, 2019
Inhibition of hedgehog signaling by stereochemically defined des-triazole itraconazole analoguesJiachen Wen, Kelly A Teske, M Kyle Hadden
Bioorganic & Medicinal Chemistry Letters|August 27, 2013
Analogues of the Inhoffen-Lythgoe diol with anti-proliferative activityAlbert M DeBerardinis, Steven Lemieux, M Kyle Hadden
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-activity relationships for side chain oxysterol agonists of the hedgehog signaling pathwayAudrey Corman, Albert M DeBerardinis, M Kyle Hadden
Pageof 8